Table of Contents

Section 1 Targeted Drugs for NSCLC Product Definition

Section 2 Global Targeted Drugs for NSCLC Market Manufacturer Share and Market Overview

• 2.1 Global Manufacturer Targeted Drugs for NSCLC Shipments
• 2.2 Global Manufacturer Targeted Drugs for NSCLC Business Revenue
• 2.3 Global Targeted Drugs for NSCLC Market Overview

Section 3 Manufacturer Targeted Drugs for NSCLC Business Introduction

• 3.1 Allergan Targeted Drugs for NSCLC Business Introduction
  • 3.1.1 Allergan Targeted Drugs for NSCLC Shipments, Price, Revenue and Gross profit 2014-2018
  • 3.1.2 Allergan Targeted Drugs for NSCLC Business Distribution by Region
  • 3.1.3 Allergan Interview Record
  • 3.1.4 Allergan Targeted Drugs for NSCLC Business Profile
  • 3.1.5 Allergan Targeted Drugs for NSCLC Product Specification
• 3.2 Amgen Targeted Drugs for NSCLC Business Introduction
  • 3.2.1 Amgen Targeted Drugs for NSCLC Shipments, Price, Revenue and Gross profit 2014-2018
  • 3.2.2 Amgen Targeted Drugs for NSCLC Business Distribution by Region
  • 3.2.3 Interview Record
  • 3.2.4 Amgen Targeted Drugs for NSCLC Business Overview
  • 3.2.5 Amgen Targeted Drugs for NSCLC Product Specification
• 3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Business Introduction
  • 3.3.1 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Shipments, Price, Revenue and Gross profit 2014-2018
  • 3.3.2 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Business Distribution by Region
  • 3.3.3 Interview Record
  • 3.3.4 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Business Overview
  • 3.3.5 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Specification
• 3.4 Beacon Pharma Limited Targeted Drugs for NSCLC Business Introduction
• 3.5 BeiGene Targeted Drugs for NSCLC Business Introduction
• 3.6 Biocon Targeted Drugs for NSCLC Business Introduction

…

Section 4 Global Targeted Drugs for NSCLC Market Segmentation (Region Level)

• 4.1 North America Country
  • 4.1.1 United States Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.1.2 Canada Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
• 4.2 South America Country
  • 4.2.1 South America Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
• 4.3 Asia Country
  • 4.3.1 China Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.3.2 Japan Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.3.3 India Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.3.4 Korea Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
• 4.4 Europe Country
  • 4.4.1 Germany Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.4.2 UK Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.4.3 France Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.4.4 Italy Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.4.5 Europe Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
• 4.5 Other Country and Region
  • 4.5.1 Middle East Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.5.2 Africa Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
  • 4.5.3 GCC Targeted Drugs for NSCLC Market Size and Price Analysis 2014-2018
• 4.6 Global Targeted Drugs for NSCLC Market Segmentation (Region Level) Analysis 2014-2018
• 4.7 Global Targeted Drugs for NSCLC Market Segmentation (Region Level) Analysis

Section 5 Global Targeted Drugs for NSCLC Market Segmentation (Product Type Level)

• 5.1 Global Targeted Drugs for NSCLC Market Segmentation (Product Type Level) Market Size 2014-2018
• 5.2 Different Targeted Drugs for NSCLC Product Type Price 2014-2018
• 5.3 Global Targeted Drugs for NSCLC Market Segmentation (Product Type Level) Analysis

Section 6 Global Targeted Drugs for NSCLC Market Segmentation (Industry Level)

• 6.1 Global Targeted Drugs for NSCLC Market Segmentation (Industry Level) Market Size 2014-2018
• 6.2 Different Industry Price 2014-2018
• 6.3 Global Targeted Drugs for NSCLC Market Segmentation (Industry Level) Analysis

Section 7 Global Targeted Drugs for NSCLC Market Segmentation (Channel Level)

• 7.1 Global Targeted Drugs for NSCLC Market Segmentation (Channel Level) Sales Volume and Share 2014-2018
• 7.2 Global Targeted Drugs for NSCLC Market Segmentation (Channel Level) Analysis

Section 8 Targeted Drugs for NSCLC Market Forecast 2018-2023

• 8.1 Targeted Drugs for NSCLC Segmentation Market Forecast (Region Level)
• 8.2 Targeted Drugs for NSCLC Segmentation Market Forecast (Product Type Level)
• 8.3 Targeted Drugs for NSCLC Segmentation Market Forecast (Industry Level)
• 8.4 Targeted Drugs for NSCLC Segmentation Market Forecast (Channel Level)

Section 9 Targeted Drugs for NSCLC Segmentation Product Type

• 9.1 Target EGFR Product Introduction
• 9.2 Target ALK Product Introduction
• 9.3 Target HER2 Product Introduction
• 9.4 Target ROS1 Product Introduction
• 9.5 Target BRAF Product Introduction

Section 10 Targeted Drugs for NSCLC Segmentation Industry

• 10.1 Squamous Cell Carcinoma of NSCLC Clients
• 10.2 Adenocarcinoma of NSCLC Clients
• 10.3 Large Cell Carcinoma of NSCLC Clients

Section 11 Targeted Drugs for NSCLC Cost of Production Analysis

• 11.1 Raw Material Cost Analysis
• 11.2 Technology Cost Analysis
• 11.3 Labor Cost Analysis
• 11.4 Cost Overview

Section 12 Conclusion

Chart and Figure

Figure Targeted Drugs for NSCLC Product Picture from Allergan

Chart 2014-2018 Global Manufacturer Targeted Drugs for NSCLC Shipments (Units)

Chart 2014-2018 Global Manufacturer Targeted Drugs for NSCLC Shipments Share

Chart 2014-2018 Global Manufacturer Targeted Drugs for NSCLC Business Revenue (Million USD)

Chart 2014-2018 Global Manufacturer Targeted Drugs for NSCLC Business Revenue Share

Chart Allergan Targeted Drugs for NSCLC Shipments, Price, Revenue and Gross profit 2014-2018

Chart Allergan Targeted Drugs for NSCLC Business Distribution

Chart Allergan Interview Record (Partly)

Figure Allergan Targeted Drugs for NSCLC Product Picture

Chart Allergan Targeted Drugs for NSCLC Business Profile

Table Allergan Targeted Drugs for NSCLC Product Specification

Chart Amgen Targeted Drugs for NSCLC Shipments, Price, Revenue and Gross profit 2014-2018

Chart Amgen Targeted Drugs for NSCLC Business Distribution

Chart Amgen Interview Record (Partly)

Figure Amgen Targeted Drugs for NSCLC Product Picture

Chart Amgen Targeted Drugs for NSCLC Business Overview

Table Amgen Targeted Drugs for NSCLC Product Specification

Chart ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Shipments, Price, Revenue and Gross profit 2014-2018

Chart ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Business Distribution

Chart ARIAD Pharmaceuticals (Takeda) Interview Record (Partly)

Figure ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Picture

Chart ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Business Overview

Table ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Specification

• 3.4 Beacon Pharma Limited Targeted Drugs for NSCLC Business Introduction

…

Chart United States Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart United States Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Canada Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart Canada Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart South America Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart South America Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart China Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart China Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Japan Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart Japan Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart India Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart India Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Korea Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart Korea Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Germany Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart Germany Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart UK Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart UK Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart France Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart France Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Italy Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart Italy Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Europe Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart Europe Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Middle East Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart Middle East Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Africa Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart Africa Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart GCC Targeted Drugs for NSCLC Sales Volume (Units) and Market Size (Million $) 2014-2018

Chart GCC Targeted Drugs for NSCLC Sales Price ($/Unit) 2014-2018

Chart Global Targeted Drugs for NSCLC Market Segmentation (Region Level) Sales Volume 2014-2018

Chart Global Targeted Drugs for NSCLC Market Segmentation (Region Level) Market size 2014-2018

Chart Targeted Drugs for NSCLC Market Segmentation (Product Type Level) Volume (Units) 2014-2018

Chart Targeted Drugs for NSCLC Market Segmentation (Product Type Level) Market Size (Million $) 2014-2018

Chart Different Targeted Drugs for NSCLC Product Type Price ($/Unit) 2014-2018

Chart Targeted Drugs for NSCLC Market Segmentation (Industry Level) Market Size (Volume) 2014-2018

Chart Targeted Drugs for NSCLC Market Segmentation (Industry Level) Market Size (Share) 2014-2018

Chart Targeted Drugs for NSCLC Market Segmentation (Industry Level) Market Size (Value) 2014-2018

Chart Global Targeted Drugs for NSCLC Market Segmentation (Channel Level) Sales Volume (Units) 2014-2018

Chart Global Targeted Drugs for NSCLC Market Segmentation (Channel Level) Share 2014-2018

Chart Targeted Drugs for NSCLC Segmentation Market Forecast (Region Level) 2018-2023

Chart Targeted Drugs for NSCLC Segmentation Market Forecast (Product Type Level) 2018-2023

Chart Targeted Drugs for NSCLC Segmentation Market Forecast (Industry Level) 2018-2023

Chart Targeted Drugs for NSCLC Segmentation Market Forecast (Channel Level) 2018-2023

Chart Target EGFR Product Figure

Chart Target EGFR Product Advantage and Disadvantage Comparison

Chart Target ALK Product Figure

Chart Target ALK Product Advantage and Disadvantage Comparison

Chart Target HER2 Product Figure

Chart Target HER2 Product Advantage and Disadvantage Comparison

Chart Target ROS1 Product Figure

Chart Target ROS1 Product Advantage and Disadvantage Comparison

Chart Target BRAF Product Figure

Chart Target BRAF Product Advantage and Disadvantage Comparison

Chart Squamous Cell Carcinoma of NSCLC Clients

Chart Adenocarcinoma of NSCLC Clients

Chart Large Cell Carcinoma of NSCLC Clients

Global Targeted Drugs for NSCLC Market Report 2019
Full Report: 2350 USD
Multi License (Section): 4700 USD
Section Price: As below
Page: 115
Chart and Figure: 124
Publisher: BisReport
Delivery Time: 24 hour
Contact: sales@bisreport.com
Phone: +86-18701006088

With the slowdown in world economic growth, the Targeted Drugs for NSCLC industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Targeted Drugs for NSCLC market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, BisReport analysts believe that in the next few years, Targeted Drugs for NSCLC market size will be further expanded, we expect that by 2023, The market size of the Targeted Drugs for NSCLC will reach XXX million $.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact BisReport

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail
Allergan
Amgen
ARIAD Pharmaceuticals (Takeda)
Beacon Pharma Limited
BeiGene
Biocon
Boehringer-Ingelheim
Celgene Corporation
Drug International Limted
Fujifilm Kyowa Kirin Biologics
Genvio Pharma Limited
Hetero Drugs
ImClone Systems ‎(Eli Lilly)
Incepta Pharmaceuticals
Mylan
Novartis
Pfizer
Reliance Lifesciences
Roche
AstraZeneca
Cipla
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Natco Pharma

Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Section (5 6 7): 500 USD——
Product Type Segmentation
Target EGFR
Target ALK
Target HER2
Target ROS1
Target BRAF

Industry Segmentation
Squamous Cell Carcinoma of NSCLC
Adenocarcinoma of NSCLC
Large Cell Carcinoma of NSCLC

Channel (Direct Sales, Distributor) Segmentation

Section 8: 400 USD——Trend (2018-2023)

Section 9: 300 USD——Product Type Detail

Section 10: 700 USD——Downstream Consumer

Section 11: 200 USD——Cost Structure

Section 12: 500 USD——Conclusion